Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.07 0.69 −1.74%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Medline Inc. (MDLN) trades at a P/E ratio of 58.4×. Over the past ten years it has ranged from 46.7× (October 2026) to 58.9× (November 2026); the current reading is higher than 96% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 50.7× 0.00%
FY2024 50.7× 0.00%
FY2023 50.7× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 50.7× 0.00%
Jun 2026 50.7× 0.00%
Mar 2026 50.7× 0.00%
Dec 2025 50.7× 0.00%
2 more quarters

Against its own ten years

Low 46.7× High 58.9×
Ten-year median 51.8×
Current reading's percentile 96

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
COO The Cooper Companies, Inc. compare 21.7×
RMD ResMed Inc. compare 21.7×
WST West Pharmaceutical Services, Inc. compare 43.8×
ISRG Intuitive Surgical, Inc. compare 55.7×
ALC Alcon compare 58.4×
MDLN Medline Inc. 58.4×
BDX Becton, Dickinson and Company compare 64.1×
SOLV Solventum Corporation compare 97.3×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MDLN